HPAS*, by age group and gender, with measured serum DHEAS
| Category | Age (years) | |||
|---|---|---|---|---|
| 5–9 | 10–14 | 15–18 | Total | |
| Males | ||||
| No HPAS | 18 | 32 | 9 | 59 |
| HPAS | 2 | 6 | 2 | 10 |
| Total | 20 | 38 | 11 | 69 |
| Females | ||||
| No HPAS | 14 | 25 | 9 | 48 |
| HPAS | 6 | 3 | 1 | 10 |
| Total | 20 | 28 | 10 | 58 |
| Total | ||||
| No HPAS | 32 | 57 | 18 | 107 |
| HPAS | 8 | 9 | 3 | 20 |
| Total | 40 | 66 | 21 | 127 |
*Postmetyrapone ACTH<106p/mL (23.3 pmol/L) AND 11DOC<208 nmol/L AND 11DOC+C<400 nmol/L.
DHEAS, dehydroepiandrosterone sulphfate; HPAS, hypothalamic–pituitary–adrenal suppression.